MedinCell S.A. (EPA:MEDCL)

MedinCell Revenue

In the fiscal year ending March 31, 2026, MedinCell had annual revenue of 24.28M EUR, down -12.44%. MedinCell had revenue of 10.13M in the half year ending March 31, 2026, with 169.06% growth.

• Revenue: 24.28M
• Revenue Growth: -12.44%
• P/S Ratio: 39.75
• Revenue / Employee: 173.41K
• Employees: 145
• Market Cap: 965.10M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	24.28M	-3.45M	-12.44%
Mar 31, 2025	27.73M	15.78M	132.12%
Mar 31, 2024	11.95M	-1.71M	-12.52%
Mar 31, 2023	13.66M	5.32M	63.77%
Mar 31, 2022	8.34M	152.00K	1.86%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 13, 2026

Data Sources Report a data error